Stem cell therapy in Bangkok for European patients at MRC Healthcare

    For patients travelling from the UK and Europe

    Stem Cell Therapy in Thailand for European and UK Patients

    In the EU and UK, cell-based treatments are regulated as advanced therapy medicinal products. Approval is product by product, which means most mesenchymal stem cell and exosome protocols are only available inside clinical trials or hospital exemption schemes. Patients from London, Frankfurt, Zurich, Paris, Amsterdam, Stockholm and Copenhagen regularly ask what treatment in Bangkok involves in practice.

    Request a remote consultationRead the full Thailand guide

    In short: stem cell therapy in Thailand for European patients

    European and UK patients travel to Bangkok because most mesenchymal stem cell protocols are classified as advanced therapy medicinal products at home and are restricted to trials or approved indications. Flights are 11 to 12 hours direct, treatment takes five to seven days, and follow-up is scheduled in your local time.

    Every protocol is prescribed and supervised by licensed Thai physicians and the cells are processed in our own GMP-aligned, ISO 9001 laboratory in Bangkok. We do not publish prices online because dosing and protocol length depend on your assessment.

    Travel

    Getting to Bangkok from Europe

    Flights

    • London to Bangkok: Direct, roughly 11 hours 30 minutes
    • Frankfurt or Munich to Bangkok: Direct, roughly 10 hours 45 minutes
    • Zurich to Bangkok: Direct, roughly 11 hours
    • Paris, Amsterdam, Stockholm or Copenhagen to Bangkok: Direct services, roughly 11 to 12 hours

    Time difference

    Bangkok is 6 hours ahead of the UK and 5 hours ahead of most of continental Europe in summer, so morning calls in Europe land in the Bangkok evening.

    Entry

    Most EU and UK passport holders do not need a visa in advance for short tourist stays in Thailand. Check the current rules for your own passport before booking.

    When to come

    November to February avoids both the European winter and the Bangkok hot season, and is the busiest period for European patients.

    How the ATMP framework shapes European options

    The EU classifies most cell therapies as advanced therapy medicinal products, and the UK follows a comparable route through the MHRA. Approval applies to a specific product for a specific indication, not to a category of treatment, so a protocol used routinely elsewhere may have no approved route at home.

    Some countries operate hospital exemption or named-patient schemes, but access is uneven and often restricted to serious conditions. Patients with degenerative joint disease, autoimmune conditions or longevity goals rarely qualify.

    Thailand's framework is different rather than absent: treatment must be prescribed and administered by licensed physicians in a licensed facility under Ministry of Public Health oversight.

    What a European patient trip looks like

    Because of the flight length, we build in a rest day before assessment. A typical stay is eight to ten days: arrival and rest, assessment and labs, treatment sessions, review, then departure.

    Sessions are day-care procedures. Patients stay in a hotel near the facility on Sukhumvit, and our team is reachable 24/7 while you are in Thailand.

    Many European patients combine treatment with a recovery period at the coast afterwards, which is straightforward once your review appointment is complete.

    Records, language and follow-up

    Send imaging and laboratory results in advance. Reports in German, French, Dutch, Swedish or Italian are usually workable, but an English summary of the key findings speeds up the review.

    Consultations at the facility are conducted in English. Follow-up calls at one, three and six months are scheduled in CET, CEST or GMT rather than Bangkok time, and you receive a written summary for your doctor at home.

    Treatments available in Bangkok

    European patients are most often treated with MSC therapy, exosome therapy, NAD+ IV therapy, NK cell therapy and PRP, for conditions including joint pain and osteoarthritis, autoimmune conditions, diabetes and metabolic health and longevity and anti-aging. The international patient guide covers the full treatment timeline and laboratory standards.

    FAQ

    Questions from European patients

    Cell-based treatments are regulated as advanced therapy medicinal products, which requires product-specific marketing authorisation based on clinical trial data. Because approval is granted product by product and indication by indication, most mesenchymal stem cell protocols have no authorised route outside trials or limited hospital exemption schemes. This is general regulatory context, not advice on your own case.

    Direct flights from major European hubs are roughly 11 to 12 hours. Plan on eight to ten days in Thailand, which allows a rest day on arrival, assessment, treatment sessions and a review before you fly home.

    Yes. Remote consultations, the in-person assessment and your written clinical summary are all in English. If you need documents summarised for a doctor at home, tell us and we will keep the wording clear and clinical.

    Public health systems and most private insurers do not reimburse elective cell therapy received outside their approval framework. Patients should plan for self-funded treatment and check their travel policy for the non-treatment portion of the trip.

    Travelling from somewhere else?

    Australia

    Patient guide for Australian patients

    Singapore

    Patient guide for Singaporean patients

    United States

    Patient guide for American patients

    Canada

    Patient guide for Canadian patients

    Start with a remote consultation

    Send your history and recent imaging or labs. Our physicians will tell you whether treatment is appropriate before you plan any travel.

    Contact MRC HealthcareAbout our doctors & lab